Skip to main content
Top
Published in: Breast Cancer Research 1/2000

01-03-2000 | Oral presentation

Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium

Authors: AF Olumi, GD Grossfeld, SW Hayward, PR Carroll, GR Cunha, P Hein, TD Tlsty

Published in: Breast Cancer Research | Special Issue 1/2000

Login to get access

Excerpt

We have demonstrated that fibroblasts associated with carcinomas stimulate tumor progression of initiated non-tumorigenic epithelial cells both in an in vivo tissue recombination system and in an in vitro co-culture system. Human carcinoma-associated fibroblasts grown with initiated human epithelial cells dramatically stimulate growth and alter histology of epithelial cells. This effect is not detected when normal fibroblasts are grown with the same epithelial cells under the same experimental conditions. From these data and other data we conclude that, in this human cancer model, carcinoma-associated fibroblasts stimulate tumor progression of an initiated epithelial cell. …
Metadata
Title
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Authors
AF Olumi
GD Grossfeld
SW Hayward
PR Carroll
GR Cunha
P Hein
TD Tlsty
Publication date
01-03-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr138

Other articles of this Special Issue 1/2000

Breast Cancer Research 1/2000 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine